title: [The problem of the cost of new oncologic therapies: what about Morocco?].
abstract: Cancer is a major public health problem in Africa. The progress in cancer treatment over the past decade is undeniable. The emergence of targeted therapies in oncology made it possible to modify the natural history of some cancers associated with a poor prognosis. Despite their efficiency, these therapies pose a major health care problem that makes them inaccessible to most patients in developing countries. In Morocco, cancer is considered a long-term condition and for this reasons patients have health insurance coverage. The involvement of civil society made it possible even to improve therapy management as well as a broader poor patient's access to innovative medicines.
authors.affiliation: Service d'Oncologie Médicale, Centre Hospitalier Mohammed VI, Oujda, Maroc.
authors.forename: Sami Aziz
authors.initials: SA
authors.lastname: Brahmi
authors.affiliation: Service d'Oncologie Médicale, Centre Hospitalier Hassan II, Fès, Maroc.
authors.forename: Ziani Fatima
authors.initials: ZF
authors.lastname: Zahra
authors.affiliation: Service d'Oncologie Médicale, Centre Hospitalier Mohammed VI, Oujda, Maroc.
authors.forename: Youssef
authors.initials: Y
authors.lastname: Seddik
authors.affiliation: Service d'Oncologie Médicale, Centre Hospitalier Mohammed VI, Oujda, Maroc.
authors.forename: Said
authors.initials: S
authors.lastname: Afqir
mesh_terms: D003906:Developing Countries / Q000191:economics; D006297:Health Services Accessibility / Q000191:economics*; D006801:Humans; D019458:Insurance Coverage / Q000191:economics*; D007348:Insurance, Health / Q000191:economics; D009018:Morocco; D009369:Neoplasms / Q000191:economics / Q000473:pathology / Q000628:therapy*
keywords: Cancer; cost; new therapies; public health